Pfizer Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||
| 26.2 | 42.1 | 46.5 | 61.1 | 74.6 | 30.8 | 19.9 | 62.4 | 17.1 | 21.5 | 16.2 | 18.2 | 14.1 | 14.1 | 16.2 | 18.5 | 18.3 | 17.2 | 4.2 | 5.5 | 5.3 | 2.0 | 22.2 | 13.0 | 22.6 | 15.2 | 9.4 | 77.1 | 18.8 | 18.2 | |
| 4.5 | 7.5 | 11.5 | 12.0 | 9.4 | 7.4 | 5.6 | 5.4 | 3.7 | 3.5 | 3.7 | 3.1 | 2.3 | 2.4 | 2.0 | 2.6 | 3.3 | 3.9 | 0.8 | 0.8 | 0.7 | 0.8 | 4.6 | 5.1 | 5.0 | 4.1 | 2.9 | 2.8 | 2.4 | 2.3 | |
| 7.3 | 11.8 | 17.7 | 21.9 | 17.3 | 13.1 | 9.1 | 3.7 | 2.8 | 2.5 | 2.5 | 2.3 | 2.0 | 1.4 | 1.5 | 2.0 | 2.2 | 2.6 | 0.5 | 0.6 | 0.6 | 0.6 | 3.9 | 3.3 | 3.3 | 4.4 | 3.1 | 1.8 | 1.7 | 1.6 | |
| 4.6 | 7.6 | 11.6 | 12.2 | 9.5 | 7.7 | 5.9 | 5.7 | 4.0 | 3.8 | 3.8 | 3.3 | 2.7 | 3.4 | 2.6 | 3.2 | 3.8 | 4.5 | 1.4 | 1.5 | 1.5 | 1.6 | 5.4 | 6.4 | 5.9 | 4.6 | 3.3 | 3.9 | 3.4 | 3.3 | |
| 16.7 | 27.0 | 25.5 | 25.1 | 29.6 | 21.4 | 14.4 | 17.9 | 10.9 | 10.7 | 9.8 | 10.7 | 8.4 | 10.0 | 9.0 | 8.9 | 10.1 | 10.0 | 3.7 | 4.8 | 5.1 | 4.2 | 14.7 | 13.9 | 18.6 | 12.1 | 8.0 | 24.4 | 11.8 | 13.6 | |
| 39.2 | 135.9 | 89.9 | 129.9 | 69.4 | 34.0 | 21.5 | 26.8 | 14.1 | 13.0 | 11.5 | 13.0 | 6.9 | 7.9 | 13.5 | 8.7 | 11.4 | 12.3 | 2.5 | 2.9 | 2.7 | 2.9 | 18.2 | 21.1 | 17.8 | 11.3 | 11.3 | 34.3 | 15.4 | 15.6 | |
| 2.6% | 0.7% | 1.1% | 0.8% | 1.4% | 2.9% | 4.6% | 3.7% | 7.1% | 7.7% | 8.7% | 7.7% | 14.6% | 12.6% | 7.4% | 11.5% | 8.8% | 8.1% | 40.2% | 33.9% | 36.6% | 34.3% | 5.5% | 4.7% | 5.6% | 8.9% | 8.9% | 2.9% | 6.5% | 6.4% | |
| Margins | ||||||||||||||||||||||||||||||
| 84.6% | 85.8% | 88.1% | 87.7% | 86.3% | 84.4% | 87.5% | 78.2% | 79.2% | 77.8% | 78.3% | 75.8% | 79.2% | 76.8% | 69.1% | 71.9% | 73.2% | 72.9% | 73.2% | 73.1% | 69.8% | 70.0% | 70.2% | 69.3% | 71.7% | 57.7% | 61.9% | 50.9% | 65.8% | 70.3% | |
| 27.2% | 26.8% | 26.6% | 28.1% | 29.3% | 34.0% | 37.9% | 23.9% | 32.5% | 30.7% | 31.2% | 28.7% | 34.4% | 32.0% | 26.4% | 30.1% | 33.0% | 32.7% | 28.3% | 27.2% | 27.0% | 27.4% | 28.5% | 18.2% | 21.8% | 25.6% | 37.4% | 8.9% | 25.9% | 24.7% | |
| 17.1% | 17.7% | 24.7% | 19.6% | 12.6% | 24.1% | 28.2% | 8.7% | 21.6% | 16.1% | 22.8% | 17.0% | 16.6% | 17.3% | 12.3% | 14.3% | 17.9% | 22.6% | 18.3% | 14.3% | 13.7% | 40.5% | 20.8% | 39.5% | 22.0% | 27.2% | 31.3% | 3.6% | 12.6% | 12.4% | |
| 11.4% | 5.5% | 12.8% | 9.2% | 13.5% | 21.9% | 26.0% | 20.1% | 26.2% | 26.6% | 32.1% | 23.7% | 34.2% | 30.8% | 14.8% | 30.4% | 28.8% | 31.6% | 30.8% | 26.6% | 26.3% | 27.1% | 25.4% | 24.3% | 27.9% | 36.7% | 25.9% | 8.0% | 15.5% | 14.5% | |
| Returns | ||||||||||||||||||||||||||||||
| 27.7% | 27.9% | 38.0% | 35.8% | 23.2% | 42.6% | 45.7% | 6.0% | 16.6% | 11.6% | 15.4% | 12.6% | 13.9% | 9.6% | 9.4% | 10.6% | 12.0% | 15.3% | 12.7% | 10.7% | 12.1% | 29.7% | 17.5% | 25.6% | 14.4% | 28.6% | 32.7% | 2.4% | 9.1% | 9.0% | |
| 13.2% | 14.4% | 18.3% | 15.5% | 11.1% | 19.9% | 19.7% | 3.3% | 9.2% | 6.5% | 9.6% | 7.1% | 7.2% | 4.1% | 4.2% | 4.6% | 5.3% | 6.8% | 5.4% | 4.2% | 4.2% | 12.4% | 7.0% | 9.7% | 5.9% | 12.2% | 15.9% | 0.9% | 3.8% | 3.7% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||
| 1,085 | 1,374 | 1,177 | 2,941 | 4,313 | 7,836 | 9,931 | 13,053 | 16,737 | 15,689 | 6,153 | 9,733 | 15,161 | 46,684 | 42,298 | 35,765 | 27,379 | 34,306 | 33,339 | 35,337 | 39,491 | 42,136 | 40,606 | 50,840 | 38,052 | 36,492 | 35,413 | 68,523 | 62,962 | 63,149 | |
| 0.3 | 0.4 | 0.2 | 0.4 | 0.5 | 0.7 | 0.7 | 0.9 | 0.9 | 0.9 | 0.3 | 0.7 | 1.0 | 2.8 | 2.2 | 1.6 | 1.3 | 1.5 | 1.7 | 2.3 | 2.6 | 2.1 | 2.1 | 2.7 | 2.9 | 1.2 | 0.9 | 7.2 | 3.5 | 4.2 | |
| 47.4% | 51.7% | 48.1% | 43.2% | 48.0% | 46.7% | 43.0% | 56.0% | 55.2% | 55.8% | 62.1% | 56.4% | 51.8% | 42.3% | 45.0% | 43.7% | 43.7% | 44.3% | 42.3% | 38.8% | 34.9% | 41.7% | 40.0% | 37.9% | 41.2% | 42.7% | 48.6% | 39.4% | 41.3% | 41.5% | |
| 0.3 | 0.3 | 0.3 | 0.6 | 0.3 | 0.5 | 0.6 | 0.2 | 0.3 | 0.3 | 0.1 | 0.2 | 0.3 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | 0.7 | 0.6 | 0.7 | 0.8 | 0.6 | 0.5 | 0.4 | 0.8 | 0.7 | 0.7 | |
| Per Share | ||||||||||||||||||||||||||||||
| 0.50 | 0.56 | 0.85 | 0.50 | 0.59 | 1.22 | 1.46 | 0.54 | 1.49 | 1.03 | 1.52 | 1.18 | 1.19 | 1.23 | 1.02 | 1.11 | 1.30 | 1.69 | 7.07 | 5.57 | 5.86 | 17.58 | 1.87 | 2.87 | 1.63 | 3.88 | 5.47 | 0.37 | 1.41 | 1.37 | |
| 2.93 | 3.16 | 3.44 | 2.57 | 4.64 | 5.07 | 5.19 | 6.20 | 6.90 | 6.40 | 6.65 | 6.98 | 7.15 | 7.10 | 8.31 | 7.76 | 7.28 | 7.48 | 38.61 | 39.04 | 42.88 | 43.37 | 8.98 | 7.25 | 7.40 | 14.24 | 17.50 | 10.43 | 11.16 | 11.01 | |
| 1.80 | 2.01 | 2.24 | 1.41 | 2.52 | 2.88 | 3.20 | 8.97 | 8.97 | 8.86 | 9.81 | 9.37 | 8.53 | 12.78 | 10.88 | 10.44 | 10.82 | 11.07 | 55.75 | 51.94 | 48.58 | 59.14 | 10.67 | 11.18 | 11.27 | 13.57 | 16.73 | 15.64 | 15.47 | 15.21 | |
| 0.34 | 0.17 | 0.44 | 0.24 | 0.63 | 1.11 | 1.35 | 1.25 | 1.80 | 1.70 | 2.14 | 1.65 | 2.45 | 2.18 | 1.23 | 2.36 | 2.09 | 2.36 | 11.91 | 10.40 | 11.29 | 11.76 | 2.28 | 1.76 | 2.06 | 5.23 | 4.54 | 0.84 | 1.73 | 1.60 | |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.